324 related articles for article (PubMed ID: 24886459)
21. Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.
Honoré C; Caruso F; Dartigues P; Benhaim L; Chirica M; Goéré D; Elias D
Anticancer Res; 2015 Sep; 35(9):4943-7. PubMed ID: 26254392
[TBL] [Abstract][Full Text] [Related]
22. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.
Ronnett BM; Yan H; Kurman RJ; Shmookler BM; Wu L; Sugarbaker PH
Cancer; 2001 Jul; 92(1):85-91. PubMed ID: 11443613
[TBL] [Abstract][Full Text] [Related]
23. The Cancer Diaspora: A Rare Case of Pseudomyxoma Peritonei of Appendiceal Origin.
Bathobakae L; Ozgur SS; Jariwala M; Kesrani J; Ajas S; Kumar M; Akmal A
J Investig Med High Impact Case Rep; 2023; 11():23247096231217822. PubMed ID: 38102072
[TBL] [Abstract][Full Text] [Related]
24. A unique presentation of superinfected pseudomyxoma peritonei secondary to a low-grade appendiceal mucinous neoplasm.
Sullivan BJ; Bolton N; Sarpel U; Magge D
World J Surg Oncol; 2019 Feb; 17(1):34. PubMed ID: 30777068
[TBL] [Abstract][Full Text] [Related]
25. Four cases of pseudomyxoma peritonei with ovarian tumors at our hospital.
Yazawa R; Yazawa H; Fukuda K; Ohara M; Osuka F
Fukushima J Med Sci; 2023 Apr; 69(1):57-65. PubMed ID: 36990788
[TBL] [Abstract][Full Text] [Related]
26. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
[TBL] [Abstract][Full Text] [Related]
27. Glycomic Profiling Highlights Increased Fucosylation in Pseudomyxoma Peritonei.
Saarinen L; Nummela P; Leinonen H; Heiskanen A; Thiel A; Haglund C; Lepistö A; Satomaa T; Hautaniemi S; Ristimäki A
Mol Cell Proteomics; 2018 Nov; 17(11):2107-2118. PubMed ID: 30072579
[TBL] [Abstract][Full Text] [Related]
28. Identifying prognostic factors in Japanese women with pseudomyxoma peritonei: a retrospective clinico-pathological study of the Tohoku Gynecologic Cancer Unit.
Kojimahara T; Nakahara K; Shoji T; Sugiyama T; Takano T; Yaegashi N; Yokoyama Y; Mizunuma H; Tase R; Satou H; Tanaka T; Motoyama T; Kurachi H
Tohoku J Exp Med; 2011 Feb; 223(2):91-6. PubMed ID: 21263209
[TBL] [Abstract][Full Text] [Related]
29. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
Pillai K; Akhter J; Chua TC; Morris DL
Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
[TBL] [Abstract][Full Text] [Related]
30. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
31. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG
Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei.
Kelly KJ; Baumgartner JM; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1722-5. PubMed ID: 25395145
[TBL] [Abstract][Full Text] [Related]
33. Pseudomyxoma peritonei syndrome of appendiceal origin: an overview.
Brueggen C; Baird G; Meisheid A
Clin J Oncol Nurs; 2007 Aug; 11(4):525-32. PubMed ID: 17723965
[TBL] [Abstract][Full Text] [Related]
34. Tumor-stroma ratio as a new prognosticator for pseudomyxoma peritonei: a comprehensive clinicopathological and immunohistochemical study.
Ma R; Lin YL; Li XB; Yan FC; Xu HB; Peng Z; Li Y
Diagn Pathol; 2021 Dec; 16(1):116. PubMed ID: 34895284
[TBL] [Abstract][Full Text] [Related]
35. Pseudomyxoma peritonei: visceral scalloping on CT is a predictor of recurrence after complete cytoreductive surgery.
Hotta M; Minamimoto R; Gohda Y; Tajima T; Kiyomatsu T; Yano H
Eur Radiol; 2020 Aug; 30(8):4193-4200. PubMed ID: 32211961
[TBL] [Abstract][Full Text] [Related]
36. Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei.
Choudry HA; Pai RK; Shuai Y; Ramalingam L; Jones HL; Pingpank JF; Ahrendt SS; Holtzman MP; Zureikat AH; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2018 Jan; 25(1):76-82. PubMed ID: 29110275
[TBL] [Abstract][Full Text] [Related]
37. MUC2, MUC5AC and MUC5B in the mucus of a patient with pseudomyxoma peritonei: biochemical and immunohistochemical study.
Mall AS; Chirwa N; Govender D; Lotz Z; Tyler M; Rodrigues J; Kahn D; Goldberg P
Pathol Int; 2007 Aug; 57(8):537-47. PubMed ID: 17610480
[TBL] [Abstract][Full Text] [Related]
38. Synchronous Ovarian and Appendiceal Mucinous Neoplasms in the Absence of Pseudomyxoma Peritonei.
Gui X; Escobar J; Lee CH; Duggan MA; Köbel M
Int J Gynecol Cancer; 2017 Feb; 27(2):214-222. PubMed ID: 27870702
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic mucin removal in patients with pseudomyxoma peritonei.
Kotani Y; Shiota M; Umemoto M; Tobiume T; Koike E; Shimaoka M; Takahashi Y; Kanemura K; Ishizu A; Hoshiai H
JSLS; 2009; 13(2):203-6. PubMed ID: 19660216
[TBL] [Abstract][Full Text] [Related]
40. Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells.
Noguchi R; Yoshimatsu Y; Sin Y; Ono T; Tsuchiya R; Yoshida H; Kiyono T; Yonemura Y; Kondo T
Hum Cell; 2024 Mar; 37(2):511-522. PubMed ID: 38143259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
